BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Pro-glucagon' and Ligand = 'BDBM142031'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Pro-glucagon


(Homo sapiens (Human))
BDBM142031
PNG
(US8927577, 12)
Show SMILES CC(C)CC(Nc1cc(C)c2ccc(F)cc2n1)c1ccc(cc1)C(=O)NCCC(O)=O
Show InChI InChI=1S/C25H28FN3O3/c1-15(2)12-21(17-4-6-18(7-5-17)25(32)27-11-10-24(30)31)28-23-13-16(3)20-9-8-19(26)14-22(20)29-23/h4-9,13-15,21H,10-12H2,1-3H3,(H,27,32)(H,28,29)(H,30,31)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
242n/an/an/an/an/an/a7.4n/a



Pfizer Inc.

US Patent


Assay Description
The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptor. Test compoun...


US Patent US8927577 (2015)


BindingDB Entry DOI: 10.7270/Q29S1PRV
More data for this
Ligand-Target Pair